Drug Screening Market 2018 Eminent Players – Alere, Thermo Fisher Scientific, Drägerwerk, Labcorp, Quest Diagnostics, Alfa Scientific Designs, Lifeloc, MPD Inc., Orasure

Drug Screening Market size is expected to grow significantly from 2018 to 2024.

Growing alcohol addiction amongst adult population is one of the major factors responsible for Drug screening market growth. Alcohol use in American adults rose from 65% to 73% in 2017 from 2016, that has boosted the demand for drug screening devices. Also, in various developing countries such as India and China, the cases of drug abuse have increased amongst the teenagers resulting in need for drug screening practices. As reported by China Real Time report, almost 51% of the teens have consumed alcohol that has surged the business growth considerably in developing countries as well. Moreover, government has enforced stringent regulations to mandate the process of drug screening.

In emerging economies such as China, growing incidences of drug abuse amongst adult as well as the teenage population has hampered the employment impeding the economic situation of the country proving to be a major factor contributing to industry growth. Also, government bodies and not-for-profit organizations focus their efforts on funding drug screening initiatives thereby augmenting drug screening practices. Although this industry has high growth rate, certain social and political decisions may restrict the market growth. For instance, political decisions such as ban on alcohol consumptions in certain countries can have a negative impact in near future.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/2745

Drug screening products business segment should occupy considerable share during the forecast timeframe owing to the increasing demand for analytical instruments. Various analytical instruments such as spectroscopy devices, inhaler devices and others for accurate detection of alcohol levels are supported by improvisations that include integration of advanced technology.

Urine samples business will experience significant surge due to extensive use of test for screening the presence of drugs such as cocaine, marijuana and opiates. In developed economies such as U.S., companies conduct drug screening urine tests before hiring any employee. As reported by medical review officer from U.S. HealthWorks, urine sample analysis for around 36,000 companies has been proposed which is most likely to result in increase in demand.

Drug treatment center business will have enormous market share due to increasing cases of drug abuses annually. Around 147,660 cases of drug abuse in medical centers from Taiwan alone have proven beneficial for the business growth. In addition, stringent government regulations have added improvisations in the devices being used in the drug treatment centers, resulting in new business practices.

U.S. drug screening market will account to the largest market share during the forecast period, owing to development of various drug testing centers. The developments include improvements in the infrastructure and services provided by these centers. For instance, Drug Testing Center of America has focused its efforts to provide the best quality and cost-effective drug testing services thereby contributing to industry size expansion.

Germany drug screening market will have a significant revenue share due to increasing rates of adoption of advanced technology. Integration of advanced technology within the devices have escalated the demand for drug screening devices that are often utilized in the laboratories for performing routine analysis of various samples.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2745

Some of the major industry players operating in the drug screening market are Alere, Thermo Fisher Scientific, Drägerwerk, Labcorp, Quest Diagnostics, Alfa Scientific Designs, Lifeloc, MPD Inc., Orasure. These industry players undertake various strategic initiatives that have helped them to evolve as major players and sustain the market competition. For instance, Quest Diagnostics has developed a platform named Drug Testing Index that enables the screening of drug use at workplace. These routine screening activities carried out at various companies have improved their productivity. Development of such platforms and services have enabled the companies to maintain sustainable profits.

Drug Screening Market By Product and Services, 2013-2024 (USD Million)
o Analytical instruments
o Rapid testing devices
o Consumables
o Drug screening services

Drug Screening Market By Sample type, 2013-2024 (USD Million)
o Urine sample
o Breath samples
o Oral fluid samples
o Hair samples
o Others

Drug Screening Market By End-user, 2013-2024 (USD Million)
o Workplace
o Hospitals
o Drug Testing Laboratories
o Others

The above information is provided for the following regions and countries:

• North America
o U.S.
o Canada

• Europe
o Germany
o UK
o France
o Italy
o Spain

• Asia Pacific
o Japan
o China
o India

• Latin America
o Mexico
o Brazil

• Middle East and Africa
o Saudi Arabia
o South Africa

Company Profiles:

• Alere
• Thermo Fisher Scientific
• Drägerwerk
• Labcorp
• Quest Diagnostics
• Alfa Scientific Designs
• Lifeloc
• MPD Inc.
• Orasure
• Omega Laboratories
• Premier Biotech
• Psychemedics
• Roche Diagnostics
• Shimadzu
• Siemens Healthineers

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.